Komori
Saftec (7464) · FactAnnual research and development expenses declined

Quarterly R&D Activity Expenses

First written in FY2018-Q1. 9 of 31 entries say "Restated". Latest entry: FY2026.

31entries
10years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseOtherFY2018-Q1 – FY20262017: 220172018: 320182019: 420192020: 420202021: 420212022: 420222023: 420232024: 320242025: 220252026: 12026
Same theme, other companies
Decline in R&D Expenses with No Change in Activity StatusA theme 50 companies write about · 22 as a headwind · 11 as a tailwind

30 other companies' latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 50 companies compared. The sentences above are computed from all 50.
Full recordFilings, disclosures and news, newest first
  1. FY2026Annual research and development expenses declinedAnnual report

    「The total research and development expense for the consolidated fiscal year was ¥535 thousand.」

    Annual research and development expense was ¥535 thousand, down from ¥658 thousand in the previous fiscal year.
  2. FY2026-H1Increase in R&D Expenses for the Interim PeriodAnnual report

    「The total amount spent on research and development activities by the Group as a whole during the interim consolidated accounting period was ¥299 thousand.」

    Interim-period research and development expense was ¥299 thousand, up from ¥192 thousand in the same period of the previous year. It stated that there were no material changes in the status of research and development activities.
  3. FY2025Decline in R&D expensesAnnual report

    「The total research and development expense for the consolidated fiscal year was ¥658 thousand.」

    Annual research and development expense was ¥658 thousand, down from ¥744 thousand in the previous fiscal year.
  4. FY2025-H1Decline in R&D expensesAnnual report

    「The total amount spent on research and development activities by the Group as a whole during the interim consolidated accounting period was ¥192 thousand.」

    Interim-period research and development expense was ¥192 thousand, down from ¥274 thousand in the same period of the previous year. It was stated that there were no material changes in the status of research and development activities.
  5. FY2024Higher R&D ExpensesAnnual report

    「The total research and development expense for the consolidated fiscal year was ¥744 thousand.」

    Annual research and development expense was ¥744 thousand, up from ¥217 thousand in the previous fiscal year.
  6. FY2024-Q3Higher R&D ExpensesAnnual report

    「The total amount spent on research and development activities by the Group as a whole during the nine-month cumulative consolidated period was ¥471 thousand. There were no material changes in the status of the Group's research and development activities during the nine-month cumulative consolidated period.」

    The nine-month cumulative research and development expense was ¥471 thousand, and it was stated that there were no material changes in the status of research and development activities.
  7. FY2024-Q2Slight decrease in R&D expensesAnnual report

    「The total amount spent on research and development activities by the Group as a whole during the six-month cumulative consolidated period was ¥274 thousand.」

    The six-month cumulative research and development expense was ¥274 thousand, down ¥2 thousand from ¥276 thousand in the same period of the previous year. It stated that there were no material changes in the status of research and development activities.
  8. FY2024-Q1Higher R&D ExpensesAnnual report

    「The total amount spent on research and development activities by the Group as a whole during the three-month cumulative consolidated period was ¥223 thousand.」

    The three-month cumulative research and development expense was ¥223 thousand, up from ¥66 thousand in the same period of the previous year. It stated that there were no material changes in the status of research and development activities.
  9. FY2023Annual research and development expenses declinedAnnual report

    「Research and development expense consisted of basic research and development expense, and the total research and development expense for the consolidated fiscal year was ¥217 thousand.」

    Annual research and development expense was ¥217 thousand, down from ¥1.316 million in the previous fiscal year.
  10. FY2023-Q3Decline in R&D expensesAnnual report

    「The total amount spent on research and development activities by the Group as a whole during the nine-month cumulative consolidated period was ¥167 thousand.」

    The nine-month cumulative research and development expense was ¥167 thousand, down from ¥670 thousand in the same period of the previous year. It stated that there were no material changes in the status of research and development activities.
  11. FY2023-Q2Decline in R&D expensesAnnual report

    「The total amount spent on research and development activities by the Group as a whole during the six-month cumulative consolidated period was ¥116 thousand.」

    The six-month cumulative research and development expense was ¥116 thousand, down from ¥276 thousand in the same period of the previous year. It stated that there were no material changes in the status of research and development activities.
  12. FY2023-Q1Decline in R&D expensesAnnual report

    「The total amount spent on research and development activities by the Group as a whole during the three-month cumulative consolidated period was ¥66 thousand.」

    The three-month cumulative research and development expense was ¥66 thousand, down from ¥226 thousand in the same period of the previous year. It stated that there were no material changes in the status of research and development activities.
  13. FY2022Higher R&D ExpensesAnnual report

    「The total research and development expense for the consolidated fiscal year was ¥1.316 million.」

    Annual research and development expense was ¥1.316 million, up from ¥619 thousand in the previous fiscal year.
  14. FY2022-Q3Higher R&D ExpensesAnnual report

    「The total amount spent on research and development activities by the Group as a whole during the nine-month cumulative consolidated period was ¥670 thousand. There were no material changes in the status of the Group's research and development activities during the nine-month cumulative consolidated period.」

    The nine-month cumulative research and development expense was ¥670 thousand, up from ¥361 thousand in the same period of the previous year. On the other hand, it was stated that there were no material changes in the status of research and development activities.
  15. FY2022-Q2Higher R&D ExpensesAnnual report

    「The total amount spent on research and development activities by the Group as a whole during the six-month cumulative consolidated period was ¥276 thousand. There were no material changes in the status of the Group's research and development activities during the six-month cumulative consolidated period.」

    The six-month cumulative research and development expense was ¥276 thousand, up from ¥212 thousand in the same period of the previous year. It stated that there were no material changes in the status of research and development activities.
  16. FY2022-Q1Higher R&D ExpensesAnnual report

    「The total amount spent on research and development activities by the Group as a whole during the three-month cumulative consolidated period was ¥226 thousand.」

    The three-month cumulative research and development expense was ¥226 thousand, up from ¥33 thousand in the same period of the previous year.
  17. FY2021Higher R&D ExpensesAnnual report

    「Research and development expense consisted of basic research and development expense, and the total research and development expense for the consolidated fiscal year was ¥619 thousand.」

    Annual research and development expense was ¥619 thousand, up from ¥585 thousand in the previous fiscal year.
  18. FY2021-Q3Decline in R&D expensesAnnual report

    「The total amount spent on research and development activities by the Group as a whole during the nine-month cumulative consolidated period was ¥361 thousand. There were no material changes in the status of the Group's research and development activities during the nine-month cumulative consolidated period.」

    The nine-month cumulative research and development expense was ¥361 thousand, down from ¥494 thousand in the same period of the previous year. It was stated that there were no material changes in the status of research and development activities.
  19. FY2021-Q2Decline in R&D expensesAnnual report

    「The total amount spent on research and development activities by the Group as a whole during the six-month cumulative consolidated period was ¥208 thousand.」

    The six-month cumulative research and development expense was ¥208 thousand, down from ¥212 thousand in the same period of the previous year. It was stated that there were no material changes in the status of research and development activities.
  20. FY2021-Q1Decline in R&D expensesAnnual report

    「The total amount spent on research and development activities by the Group as a whole during the three-month cumulative consolidated period was ¥33 thousand.」

    The three-month cumulative research and development expense was ¥33 thousand, down from ¥92 thousand in the same period of the previous year.
  21. FY2020Decline in R&D expensesAnnual report

    「The total research and development expense for the consolidated fiscal year was ¥585 thousand.」

    Annual research and development expense was ¥585 thousand, down from ¥1.261 million in the previous fiscal year.
  22. FY2020-Q3RestatedAnnual report

    「The total amount spent on research and development activities by the Group as a whole during the nine-month cumulative consolidated period was ¥494 thousand.」

    The nine-month cumulative research and development expense was ¥494 thousand, and it was stated that there were no material changes in the status of research and development activities.
  23. FY2020-Q2RestatedAnnual report

    「The total amount spent on research and development activities by the Group as a whole during the six-month cumulative consolidated period was ¥212 thousand. There were no material changes in the status of the Group's research and development activities during the six-month cumulative consolidated period.」

    The six-month cumulative research and development expense was ¥212 thousand, and it was stated that there were no material changes in the status of research and development activities.
  24. FY2020-Q1RestatedAnnual report

    「The total amount spent on research and development activities by the Group as a whole during the three-month cumulative consolidated period was ¥92 thousand.」

    The three-month cumulative research and development expense was ¥92 thousand. It was also stated that there were no material changes in the status of research and development activities.
  25. FY2019RestatedAnnual report

    「The total research and development expense for the consolidated fiscal year was ¥1.261 million.」

    The Company continued research and development of products to meet customer needs, and annual research and development expense was ¥1.261 million.
  26. FY2019-Q3RestatedAnnual report

    「The total amount spent on research and development activities by the Group as a whole during the nine-month cumulative consolidated period was ¥1.095 million. There were no material changes in the status of the Group's research and development activities during the nine-month cumulative consolidated period.」

    The nine-month cumulative research and development expense was ¥1.095 million, and it was stated that there were no material changes in the status of research and development activities.
  27. FY2019-Q2RestatedAnnual report

    「The total amount spent on research and development activities by the Group as a whole during the six-month cumulative consolidated period was ¥653 thousand. There were no material changes in the status of the Group's research and development activities during the six-month cumulative consolidated period.」

    The six-month cumulative research and development expense was ¥653 thousand, and it was stated that there were no material changes in the status of research and development activities.
  28. FY2019-Q1RestatedAnnual report

    「The total amount spent on research and development activities by the Group as a whole during the three-month cumulative consolidated period was ¥309 thousand. There were no material changes in the status of the Group's research and development activities during the three-month cumulative consolidated period.」

    The three-month cumulative research and development expense was ¥309 thousand, and it was stated that there were no material changes in the status of research and development activities.
  29. FY2018-Q3RestatedAnnual report

    「The total amount spent on research and development activities by the Group as a whole during the nine-month cumulative consolidated period was ¥2.736 million. There were no material changes in the status of the Group's research and development activities during the nine-month cumulative consolidated period.」

    The nine-month cumulative research and development expense was ¥2.736 million, and it was stated that there were no material changes in the status of research and development activities.
  30. FY2018-Q2RestatedAnnual report

    「The total amount of research and development activities conducted by the Group during the cumulative second quarter was ¥2.143 million. There were no material changes in the status of the Group's research and development activities during the cumulative second quarter.」

    Research and development expenses were ¥2.143 million, and it was stated that there had been no material changes in the status of research and development activities.
  31. FY2018-Q1First statedAnnual report

    「The total amount of research and development activities conducted by the Group during the cumulative first quarter was ¥2.034 million.」

    The total research and development expenses for the cumulative first quarter were first recorded in the thread. It was also stated that there had been no material changes in the Group's research and development activities.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Saftec's next results are scheduled for 2026-10-30. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.